CN Patent
CN104434808A — 一种治疗性纳米粒子及其制备方法
Assigned to CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd · Expires 2015-03-25 · 11y expired
What this patent protects
本公开提供一种治疗性纳米粒子及其制备方法。本公开的治疗性纳米粒子包含活性成分和人血清白蛋白,其中治疗性纳米粒子中人血清白蛋白和活性成分的重量比为0.01∶1至1∶1。本公开还提供一种药物组合物,含有上述的治疗性纳米粒子。本公开还提供一种制备上述治疗性纳米粒子和组合物的方法。
USPTO Abstract
本公开提供一种治疗性纳米粒子及其制备方法。本公开的治疗性纳米粒子包含活性成分和人血清白蛋白,其中治疗性纳米粒子中人血清白蛋白和活性成分的重量比为0.01∶1至1∶1。本公开还提供一种药物组合物,含有上述的治疗性纳米粒子。本公开还提供一种制备上述治疗性纳米粒子和组合物的方法。
Drugs covered by this patent
- Taxotere (Docetaxel) · Sanofi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.